White House press secretary Kayleigh McEnany calls on a reporter during a ... pandemic, by this disease, this — whatever they want to call it,” Trump said. ... “Well, as you know, this was a novel pathogen[color=red][/color],” McEnany replied.
“Revive Therapeutics is exploring the use of the drug Bucillamine as a potential novel treatment for infectious diseases including influenza and the coronavirus disease (Covid-19),” reported Equity Guru’s Chris Parry on April 23, 2020.
News 
Market Data 
Discover 
